Preclinical study suggests ARID1a mutations may help predict immunotherapy success – News-Medical.net
News-Medical.net |
Preclinical study suggests ARID1a mutations may help predict immunotherapy success
News-Medical.net Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer … |
